Esther Cho
Chief Legal Officer · Keros Therapeutics, Inc.
IndividualSelling only
- 2026
- Aug 20, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Esther Cho files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ADAR1 Capital Management, LLC - $95.66M in KROS purchases and sales in the last 12 months
- Pontifax Management 4 G.P. (2015) Ltd. - $84.98M in KROS purchases and sales in the last 12 months
- Jasbir Seehra - $113K in KROS purchases and sales in the last 12 months
- Lorena Raquel Lerner - $100K in KROS purchases and sales in the last 12 months
- Keith Regnante - $77K in KROS purchases and sales in the last 12 months
- Jean Jacques Bienaime - $76K in KROS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Esther Cho?
Esther Cho is a corporate insider, tracked as Chief Legal Officer of Keros Therapeutics, Inc. (KROS). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Esther Cho submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Esther Cho been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($124K) across all tracked filings.
